Inflammatory Bowel Disease Treatment Goals
18 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is a primary goal of IBD treatment?

  • Eradicate the disease completely.
  • Focus on dietary modifications only.
  • Cure the condition through surgery.
  • Control inflammation and improve quality of life. (correct)
  • Why are drugs the preferred treatment for Crohn's disease over surgery?

  • There are no effective drug therapies for Crohn's disease.
  • Drugs are less expensive than surgery.
  • Surgery is only effective for ulcerative colitis.
  • The recurrence rate is high after surgical treatment. (correct)
  • Which of the following is NOT a major drug class used to treat IBD?

  • Antifungals (correct)
  • Immunomodulators
  • Aminosalicylates
  • Antimicrobials
  • What is the initial treatment for Ulcerative Colitis (UC)?

    <p>Corticosteroid for symptom relief with an aminosalicylate or biologic therapy. (A)</p> Signup and view all the answers

    What is the primary mechanism of action of 5-aminosalicylic acid (5-ASA) drugs?

    <p>Suppresses the production of pro-inflammatory cytokines and mediators. (D)</p> Signup and view all the answers

    What is an advantage of using rectal administration of aminosalicylates?

    <p>It allows for direct delivery of the medication to the affected tissues. (A)</p> Signup and view all the answers

    How do biologics reduce IBD-related inflammation?

    <p>By blocking specific proteins that play a role in inflammation. (C)</p> Signup and view all the answers

    What type of biologic therapy is infliximab (Remicade)?

    <p>Anti-TNF agent (A)</p> Signup and view all the answers

    Which of the following is NOT a common side effect associated with anti-TNF agents?

    <p>Hypersensitivity reactions (B)</p> Signup and view all the answers

    A patient is about to start therapy with an anti-TNF agent. Which of the following tests is essential before beginning treatment?

    <p>Tuberculosis and hepatitis screening (B)</p> Signup and view all the answers

    Which of the following best describes the mechanism of action of alpha 4-integrin inhibitors?

    <p>Inhibiting leukocyte adhesion (A)</p> Signup and view all the answers

    Which medication requires a restricted program due to the risk for progressive multifocal leukoencephalopathy?

    <p>Natalizumab (B)</p> Signup and view all the answers

    What is the primary action of IL-12/23 antagonists in the treatment of inflammatory bowel disease?

    <p>To prevent the activation of T-helper and natural killer cells (C)</p> Signup and view all the answers

    Which drug class is known to suppress the immune system by blocking the JAK enzyme?

    <p>JAK inhibitors (C)</p> Signup and view all the answers

    Why are corticosteroids given for the shortest possible time in treating inflammatory bowel disease?

    <p>To minimize long-term side effects (B)</p> Signup and view all the answers

    A patient with inflammation in the left colon, sigmoid, and rectum would benefit from which type of corticosteroid administration?

    <p>Suppositories, enemas, and foams (D)</p> Signup and view all the answers

    Which of the following best describes immunogenicity in the context of biologic therapies?

    <p>The ability to induce the production of antibodies against the drug (D)</p> Signup and view all the answers

    When is stopping and restarting a biologic drug most likely to cause infusion reactions?

    <p>When the drug is stopped and then restarted (A)</p> Signup and view all the answers

    Study Notes

    Inflammatory Bowel Disease (IBD) Treatment Goals

    • IBD treatment aims to:
      • Rest the bowel
      • Control inflammation
      • Correct malnutrition
      • Provide symptomatic relief
      • Improve quality of life
    • No cure exists for IBD

    Drug Therapy for IBD

    • The goal is to induce and maintain remission
    • Five main drug classes are used:
      • Aminosalicylates
      • Antimicrobials
      • Corticosteroids
      • Immunomodulators
      • Biologic therapies
    • Drug choice depends on inflammation location and severity
    • Initial ulcerative colitis (UC) treatment includes corticosteroids for symptom relief, then aminosalicylates or biologics based on severity
    • Crohn's disease management also includes biologics and corticosteroids, possibly as combinations.

    Aminosalicylates (5-ASA)

    • Treat both UC and Crohn's, being more effective for UC
    • Mechanism unclear, thought to suppress pro-inflammatory cytokines and mediators
    • Administered orally or rectally
    • Oral forms have different coatings affecting drug release, improving targeted symptom relief
    • Rectal delivery is beneficial for inflammation in rectum/large intestine
    • Combination therapy (oral and rectal) is better than oral or rectal alone.

    Biologic Therapies

    • Reduce IBD inflammation by blocking specific inflammatory proteins
    • Four main classes:
      • Anti-TNF agents
      • Alpha 4-integrin inhibitors
      • IL-12/23 antagonists
      • JAK inhibitors
    • Anti-TNF agents (e.g., infliximab) are given intravenously (IV) to induce/maintain remission in UC/Crohn's
    • Other anti-TNF agents are subcutaneous (SQ)
    • Common side effects (all anti-TNF agents): upper respiratory/urinary tract infections, headaches, nausea, joint/abdominal pain
    • More serious side effects: hepatitis reactivation, TB, opportunistic infections, cancers (especially lymphoma)
    • Testing for TB and hepatitis is required before starting anti-TNF therapy
    • Active infections delay treatment
    • Live virus immunizations are contraindicated
    • Education on preventing/recognizing infection symptoms (fever, cough, malaise, dyspnea) is crucial

    Alpha 4-Integrin Inhibitors

    • (e.g., natalizumab, vedolizumab)
    • Inhibit leukocyte adhesion by blocking α4-integrin
    • Only used when other therapies (corticosteroids, immunomodulators, anti-TNFs) haven't been effective
    • Administered by IV infusion
    • Side effects include increased infection risk, liver toxicity, and hypersensitivity reactions
    • Natalizumab is restricted for use.

    IL-12/23 Antagonists

    • (e.g., ustekinumab, risankizumab)
    • Inhibit IL-12 and IL-23, preventing T-helper and natural killer cell activation
    • Administered by IV first dose, then via injections every 8 weeks.
    • Precautions and side effects similar to anti-TNF agents.

    JAK Inhibitors

    • (e.g., tofacitinib)
    • Suppress the immune system by blocking the JAK enzyme.
    • Prevent immune cell activation causing inflammation.
    • TB testing required before starting
    • Should not be combined with other biologics or immunomodulators

    Corticosteroids

    • Decrease intestinal mucosa inflammation
    • Short-term use due to side effects of long-term use
    • Suppositories, enemas, and foams deliver corticosteroids directly to inflamed tissue in the sigmoid, rectum, and left colon.
    • Oral prednisone is for mild-to-moderate disease unresponsive to 5-ASA.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the treatment goals for Inflammatory Bowel Disease (IBD), focusing on managing symptoms and improving quality of life. It explores various drug therapies, including aminosalicylates and corticosteroids, and discusses their effectiveness for different types of IBD. Test your knowledge on the current practices in IBD management.

    More Like This

    Treating Inflammatory Bowel Disease (IBD)
    16 questions
    Constipation Relief and IBD Treatments
    25 questions
    Use Quizgecko on...
    Browser
    Browser